What's Happening?
Japan's Nissha Co., Ltd. has acquired a 60% stake in USM Healthcare Medical Devices Factory JSC, a Vietnam-based manufacturer of cardiovascular stents. This acquisition, effective May 20, 2026, marks Nissha's strategic expansion into Southeast Asia. The
deal involves Nissha directly purchasing a 59.99% stake, with its subsidiary, Nissha Vietnam Co., Ltd., acquiring an additional 0.01%. USM Healthcare, established in 2012, operates a manufacturing facility in Ho Chi Minh City and is Vietnam's sole domestic producer of stents. The company also manufactures orthopedic devices and engages in product design, development, and sales. Nissha's acquisition aims to leverage USM Healthcare's capabilities to enhance its medical-device manufacturing and export network in the region.
Why It's Important?
This acquisition is significant as it positions Nissha to capitalize on the growing healthcare market in Southeast Asia, driven by economic development and rising healthcare standards. By integrating USM Healthcare into its operations, Nissha can expand its customer base in the U.S. and Japan while enhancing its medical-device design and manufacturing capabilities. The move aligns with Vietnam's strategy to attract foreign investment in high-tech industries, potentially elevating USM Healthcare's role in the global medical-device supply chain. This could lead to increased production standards and access to international markets, benefiting both Nissha and Vietnam's medical-device sector.
What's Next?
Nissha plans to optimize USM Healthcare's operations by leveraging its expertise in medical-device design and manufacturing. The company aims to expand its geographic footprint across Southeast Asia, potentially transforming USM Healthcare into a key player in Nissha's global supply chain. This strategic integration may involve upgrading manufacturing standards and quality management, positioning USM Healthcare to serve not only the Vietnamese market but also international customers. The success of this integration could serve as a model for industrial upgrading in Vietnam's medical-device sector.
